Redondo Beach, CA, United States of America

Michael R Yeaman

This inventor holds 24 USPTO granted patents and 19 published patent applications, plus 2 CIPO patents and 7 EPO patents. Top assignees: Los Angeles Biomedical Research Institute at Harbor-Ucla Medical Center, The Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center, Novadigm Therapeutics, Inc.. Active years: 2004-2026.

USPTO Granted Patents = 24 

% Patents Active = 87.5

 

 

Average Co-Inventor Count = 2.3

ph-index = 3

Forward Citations = 38(Granted Patents)


Location History:

  • Torrance, CA (US) (2004 - 2010)
  • Redondo Beach, CA (US) (2006 - 2024)

Company Filing History:


Years Active: 2004-2026

Loading Chart...
Loading Chart...
Loading Chart...
24 patents (USPTO):Explore Patents

Title: The Inventive Journey of Michael R Yeaman

Introduction: Michael R Yeaman, a talented inventor hailing from Redondo Beach, CA, has made significant contributions to the field of innovations with his groundbreaking ideas and inventions.

Latest Patents: Michael R Yeaman holds several patents in various industries, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: Throughout his illustrious career, Michael R Yeaman has been recognized for his exceptional problem-solving skills and ability to think outside the box. His inventions have revolutionized the way we approach challenges in different sectors.

Collaborations: Michael R Yeaman has collaborated with leading companies, research institutions, and universities to bring his inventions to life. His partnerships have led to the development of cutting-edge technologies that have had a lasting impact on the industry.

Conclusion: Michael R Yeaman's passion for innovation and dedication to pushing the boundaries of what is possible make him a true pioneer in the world of inventions. His work continues to inspire the next generation of inventors to dream big and create a better future through their ideas.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…